Cargando…
Prediction of individualized therapeutic vulnerabilities in cancer from genomic profiles
Motivation: Somatic homozygous deletions of chromosomal regions in cancer, while not necessarily oncogenic, may lead to therapeutic vulnerabilities specific to cancer cells compared with normal cells. A recently reported example is the loss of one of the two isoenzymes in glioblastoma cancer cells s...
Autores principales: | Aksoy, Bülent Arman, Demir, Emek, Babur, Özgün, Wang, Weiqing, Jing, Xiaohong, Schultz, Nikolaus, Sander, Chris |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4080742/ https://www.ncbi.nlm.nih.gov/pubmed/24665131 http://dx.doi.org/10.1093/bioinformatics/btu164 |
Ejemplares similares
-
Integrating biological pathways and genomic profiles with ChiBE 2
por: Babur, Özgün, et al.
Publicado: (2014) -
Systematic identification of cancer driving signaling pathways based on mutual exclusivity of genomic alterations
por: Babur, Özgün, et al.
Publicado: (2015) -
PaxtoolsR: pathway analysis in R using Pathway Commons
por: Luna, Augustin, et al.
Publicado: (2016) -
Pattern search in BioPAX models
por: Babur, Özgün, et al.
Publicado: (2014) -
Perturbation biology nominates upstream–downstream drug combinations in RAF inhibitor resistant melanoma cells
por: Korkut, Anil, et al.
Publicado: (2015)